not vested
Genting Malaysia (GENM MK)
2Q22: Best Quarterly Results Since Onset of Pandemic
GENM charted its best quarterly EBITDA since the onset of the pandemic, mainly driven
by RWG’s strong recovery (achieving 75% of pre-pandemic revenue).
We anticipate further recovery in 2H22, premised on RWG’s stronger international patronage and room for capacity expansion.
Key catalysts for GENM include sharp GGR growth, restoration of its dividend practice by end-22 (implying about 5% yield), and RWNYC bidding for a full-fledged casino licence.
Maintain BUY. Target price: RM4.00.
Source: UOBKH
https://research.uobkayhian.com/content ... 048d8504e3